Literature DB >> 21953360

[Typus melancholicus from tellenbach up to the present day: a review about the premorbid personality vulnerable to melancholia].

Alessandra Ambrosini1, Giovanni Stanghellini, Alvaro I Langer.   

Abstract

The concept of Typus Melancholicus (TM) was shaped by Tellenbach to describe the premorbid and intermorbid personality vulnerable to endogenous depression. The first part of this paper aims to point out the basic principles of Tellenbach’s theory – the method, the concept of endon, of rhythmic, of situation, of rimanence, of includence and of despair. Then, we present a systematic description of the premorbid personality features - orderliness, conscientiousness, hyper/hetereonomia and intolerance of ambiguity. Furthermore, we present two clinical cases, one from Tellenbach and the other from our clinical practice to underline the typical way which links the premorbid condition to melancholia. Also, we propose a review of the scientific literature from Tellenbach’s work to the present day. Finally, we discuss the clinical importance of the TM construct.

Entities:  

Mesh:

Year:  2011        PMID: 21953360

Source DB:  PubMed          Journal:  Actas Esp Psiquiatr        ISSN: 1139-9287            Impact factor:   1.196


  3 in total

1.  Effect of Affective Temperaments Assessed by the TEMPS-A on the Relationship between Work-Related Stressors and Depressive Symptoms among Workers in Their Twenties to Forties in Japan.

Authors:  Maki Tei-Tominaga; Tsuyoshi Akiyama; Yoshie Sakai
Journal:  Depress Res Treat       Date:  2012-09-06

2.  COVID-19 related lockdown: a trigger from the pre-melancholic phase to catatonia and depression, a case report of a 59 year-old man.

Authors:  Giuseppe Sarli; Lorenzo Polidori; David Lester; Maurizio Pompili
Journal:  BMC Psychiatry       Date:  2020-11-25       Impact factor: 3.630

3.  Clinical patterns and treatment outcome in patients with melancholic, atypical and non-melancholic depressions.

Authors:  Margalida Gili; Miquel Roca; Silvia Armengol; David Asensio; Javier Garcia-Campayo; Gordon Parker
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.